Cargando…
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
Treatment of chemo-resistant ovarian cancer (OvCa) remains clinically challenging and there is a pressing need to identify novel therapeutic strategies. Here we report that multiple mechanisms that promote OvCa progression and chemo-resistance could be inhibited by ectopic expression of miR-15a and...
Autores principales: | Dhar Dwivedi, Shailendra Kumar, Mustafi, Soumyajit Banerjee, Mangala, Lingegowda S., Jiang, Dahai, Pradeep, Sunila, Rodriguez-Aguayo, Cristian, Ling, Hui, Ivan, Cristina, Mukherjee, Priyabrata, Calin, George A., Lopez-Berestein, Gabriel, Sood, Anil K., Bhattacharya, Resham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924772/ https://www.ncbi.nlm.nih.gov/pubmed/26918603 http://dx.doi.org/10.18632/oncotarget.7618 |
Ejemplares similares
-
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2016) -
Bone protection by inhibition of microRNA-182
por: Inoue, Kazuki, et al.
Publicado: (2018) -
BMI1, a new target of CK2α
por: Banerjee Mustafi, Soumyajit, et al.
Publicado: (2017) -
microRNA Therapeutics in Cancer — An Emerging Concept
por: Shah, Maitri Y., et al.
Publicado: (2016) -
Bmi-1: At the crossroads of physiological and pathological biology
por: Bhattacharya, Resham, et al.
Publicado: (2015)